With the fate of the Affordable Care Act in the Supreme Court’s hands, we consider this week some other aspects of health care practice — regulatory hurdles to the use of emote diagnostic and treatment technologies that would allow elderly people to remain in their homes longer; a new complication for the defense side in whistleblower cases; and the targeting of the life-sciences industry by patent assertion entities.
Regulations Lag Behind ‘Telehealth’ Technology
Remote, 24-hour monitoring would allow Americans who need long-term care to “age in place” at home.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]